Adverum Biotechnologies, Inc. (ADVM) Social Stream



Adverum Biotechnologies, Inc. (ADVM): $0.68

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ADVM to Watchlist
Sign Up

Industry: Biotech


Ranked

of 380

in industry

ADVERUM BIOTECHNOLOGIES INC (ADVM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ADVM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 4 $6 $3 $4.333 $0.691 527.06%
2022-03-30 4 $6 $4 $5 $0.691 623.59%
2022-04-11 4 $4 $3 $3.5 $0.691 406.51%
2022-05-15 3 $4 $3 $3.5 $0.691 406.51%
2022-05-27 3 $3 $3 $3 $0.691 334.15%
2022-07-07 3 $4 $3 $3.5 $0.691 406.51%
2022-08-15 3 $4 $2.5 $3.25 $0.691 370.33%
2022-08-16 3 $6 $2.5 $4.25 $0.691 515.05%
2022-11-14 4 $6 $2 $3.666 $0.691 430.54%

The Trend in the Analyst Price Target


ADVM's average price target has moved down $21.55 over the prior 23 months.

Over the past 33 weeks, ADVM's average upside potential has been 240.35%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-30 4 6 4 5.0 1.34 273.13%
2022-03-30 3 6 4 5.0 1.34 273.13%
2022-04-11 4 4 3 3.5 1.17 199.15%
2022-04-11 3 4 3 3.5 1.17 199.15%
2022-07-07 3 4 3 3.5 1.40 150%

ADVM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 2 0 2 0 0 4

The Trend in the Broker Recommendations


ADVM's average broker recommendation rating improved by 0.67 over the prior 16 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, ADVERUM BIOTECHNOLOGIES INC's average analyst price target is higher than 31.44% of them.
  • ADVERUM BIOTECHNOLOGIES INC's upside potential (average analyst target price relative to current price) is greater than 1095.97% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, ADVERUM BIOTECHNOLOGIES INC's number of analysts covering the stock is greater than 256.14% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, ADVERUM BIOTECHNOLOGIES INC's variance in analysts' estimates is lower than -484.11% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ADVERUM BIOTECHNOLOGIES INC are AGTC, CHRS, and ATRA.

Is ADVM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6652 seconds.